July 2 (Reuters) - Kitov Pharma Ltd:
* KITOV PHARMA ISSUES CEO SHAREHOLDER LETTER PROVIDING BUSINESS UPDATE
* KITOV PHARMA LTD - AS OF END OF JUNE 2020, HAD OVER $60 MILLION IN CASH
* KITOV PHARMA LTD - CONSENSI EXPECTED TO BEGIN GENERATING ROYALTY REVENUE FOR KITOV THIS YEAR
* KITOV PHARMA LTD - CURRENT CASH RUNWAY IS EXPECTED TO SUPPORT OUR CURRENTLY PLANNED ACTIVITIES INTO AT LEAST 2024
* KITOV PHARMA LTD - BELIEVE WE ARE WELL-FUNDED TO EXECUTE OUR STRATEGIC PLANS
* KITOV PHARMA LTD - EXPECT TO RECEIVE MILESTONE & ROYALTY REVENUES OF BETWEEN $28 MILLION & $36 MILLION FROM 2020 THROUGH 2022, IN AGREEMENT FOR CONSENSI Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.